Repositorio Dspace

A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.

Mostrar el registro sencillo del ítem

dc.contributor.author Jiménez, Víctor-A
dc.contributor.author Íñiguez, Andrés
dc.contributor.author Baz, José-A
dc.contributor.author Valdés-Chavarri, Mariano
dc.contributor.author Ortiz, Alberto
dc.contributor.author Vuilliomenet, Andre
dc.contributor.author Mainar, Vicente
dc.contributor.author Dudek, Dariusz
dc.contributor.author Banai, Shmuel
dc.contributor.author Tuller, David
dc.contributor.author Bonnet, Jean-Louis
dc.contributor.author de-Miguel, Antonio
dc.contributor.author Bastos, Guillermo
dc.contributor.author Wijns, William
dc.contributor.author Saito, Shigeru
dc.date.accessioned 2026-10-21T06:20:11Z
dc.date.available 2026-10-21T06:20:11Z
dc.date.issued 2016-09
dc.identifier.citation Jiménez VA, Iñiguez A, Baz JA, Valdés M, Ortiz A, Vuilliomenet A, et al. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy. Cardiovascular Revascularization Medicine. septiembre de 2016;17(6):355-61. doi:10.1016/j.carrev.2016.04.001
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28900
dc.description.abstract BACKGROUND: To investigate clinical outcomes of percutaneous coronary intervention using a sirolimus-eluting stent with bioresorbable polymer, Ultimaster (BP-SES) compared with a permanent polymer everolimus-eluting stent, Xience (PP-EES) in patients with high risk (ST-segment elevation and non-ST-segment elevation myocardial infarction) acute coronary syndromes (ACS) enrolled in the CENTURY II trial. METHODS: CENTURY II is a prospective, multicenter, randomized, single blind, controlled trial comparing BP-SES and PP-EES, with primary endpoint of target lesion failure (TLF) at 9month post-stent implantation. Out of 1123 patients enrolled in CENTURY II trial, 264 high risk ACS patients were included in this subgroup analysis, and the clinical outcomes including target lesion failure (TLF), target vessel failure (TVF), cardiac death, myocardial infarction, and stent thrombosis were evaluated at 24months. RESULTS: The baseline clinical, angiographic and procedural characteristics were similar between two groups. At 24months, TLF occurred in 6.3% of patients receiving a BP-SES and 6.5% of patients receiving a PP-EES (P=0.95); TVF was 6.3% in patients receiving a BP-SES and 9.4% in patients receiving a PP-EES (P=0.36). There were no significant differences in cardiac death, myocardial infarction and stent thrombosis rate. CONCLUSIONS: BP-SES achieved similar safety and efficacy outcomes as PP-EES in this ACS subgroup of CENTURY II study, at 24-month follow-up. This finding is hypothesis-generating and needs to be confirmed in larger trials with longer follow-up.
dc.language.iso eng
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Absorbable Implants
dc.subject.mesh Acute Coronary Syndrome/diagnostic imaging/mortality/therapy
dc.subject.mesh Aged
dc.subject.mesh Cardiovascular Agents/administration & dosage
dc.subject.mesh Coronary Angiography
dc.subject.mesh Coronary Restenosis/etiology
dc.subject.mesh Drug-Eluting Stents
dc.subject.mesh Europe
dc.subject.mesh Everolimus/administration & dosage
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Japan
dc.subject.mesh Kaplan-Meier Estimate
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Non-ST Elevated Myocardial Infarction/diagnostic imaging/mortality/therapy
dc.subject.mesh Percutaneous Coronary Intervention/adverse effects/instrumentation/mortality
dc.subject.mesh Polymers/chemistry
dc.subject.mesh Prospective Studies
dc.subject.mesh Prosthesis Design
dc.subject.mesh Recurrence
dc.subject.mesh Republic of Korea
dc.subject.mesh Risk Factors
dc.subject.mesh ST Elevation Myocardial Infarction/diagnostic imaging/mortality/therapy
dc.subject.mesh Single-Blind Method
dc.subject.mesh Thrombosis/etiology
dc.subject.mesh Time Factors
dc.subject.mesh Treatment Outcome
dc.title A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 27156201
dc.relation.publisherversion https://linkinghub.elsevier.com/retrieve/pii/S1553838916301051
dc.identifier.doi 10.1016/j.carrev.2016.04.001
dc.journal.title Cardiovascular Revascularization Medicine: Including Molecular Interventions
dc.identifier.essn 1878-0938


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta